JOHN PATRICK OROHO, Executive Vice President and Chief Strategy Officer of Porzio Life Sciences, LLC, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their practices in meeting compliance requirements of all 50 states and the District of Columbia.

Mr. Oroho is also a principal of the law firm, Porzio, Bromberg & Newman P.C., and practices in the Life Sciences Compliance and Regulatory Counseling Department. He concentrates his law practice in regulatory compliance with respect to the Prescription Drug Marketing Act (PDMA), Anti­kickback statute, False Claim Act, and Medicare and Medicaid fraud and abuse.

Mr. Oroho previously served as Senior Vice President and General Counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance.

Mr. Oroho has an extensive pharmaceutical regulatory and compliance background. He spent three years as General Counsel for the company now known as QPharma, Inc.

Mr. Oroho received a J.D. from the University of Notre Dame School of Law in 1985 and a B.S. from the United States Merchant Marine Academy, where he graduated with honors in 1978.

"European Healthcare Compliance Certification," Seton Hall European Healthcare Compliance Program, Paris, France, November 2012.

SPEAKING ENGAGEMENTS

  • "Track Chair's Opening Remarks, Transparency and Aggregate Spend Section," CBI's 15th Annual Pharmaceutical Compliance Congress, Washington, DC, April 25, 2018. 
  • "Summit Host Welcome and Anti-Trust Guideline Reminders," CBI's 15th Annual Pharmaceutical Compliance Congress, Washington, DC, April 24, 2018.
  • "U.S. Enforcement Landscape," Medical Device Regulation and MedTech Europe Code of Ethics Business Practices Summit, London, UK, April 10, 2018.
  • "HCP Engagement Restrictions," Maritz Healthcare Advisory Council Meeting, Philadelphia, PA, February 27, 2018.
  • "Mini Summit XVI: Compliance Considerations for Small and Mid-Sized Pharma and Medical Device Companies," 18th Annual Pharmaceutical and Medical Device Compliance Congress, Washington, DC, November 7, 2017.  
  • "Understanding Federal and State Reporting Laws from All Corners," Seton Hall Law School's U.S. Healthcare Compliance Certification Program, Newark, NJ, October 11, 2017.
  • "How to Prepare for a Potential CMS Audit," "Your Data…The Government is Watching," CBI's 11th Annual Forum on Transparency & Aggregate Spend, Washington, DC, August 15, 2017.
  • "Navigating State, Federal, and International Transparency Disclosure Requirements," Healthcare Compliance Certification Program, Seton Hall Law, Center for Health & Pharmaceutical Law & Policy, Newark, NJ, June 14, 2017.
  • "Preparing for the Possibility of an Open Payments Audit – Your Data…The Government is Watching," The 8th Annual West Coast Forum on Transparency & Aggregate Spend, Leverage Data Analytics to Create Business Value, San Diego, CA, May 23, 2017.
  • "Aggregate Spend – 20 Things to Know About Transparency," 13th Annual Medical Device Compliance Congress, San Diego, CA, May 22, 2017.
  • "Summit Host Welcome and Anti-Trust Guideline Reminders," CBI's 14th Annual Pharmaceutical Compliance Congress, Washington, DC, April 27, 2017.
  • "Staying Ahead of Current and Emerging Regulations Impacting Sample Reporting and Compliance," CBI's Next Generation Pharmaceutical Samples, Philadelphia, PA, April 12, 2017. 
  • Panelist, "The State of the Life Science Industry," The Morris County Economic Development Corporation, 25th Annual Awards Luncheon, Whippany, New Jersey, March 10, 2017.
  • “Understanding Disclosure Laws from All Corners," Synergistix User’s Conference 2017, Fort Lauderdale, FL, March 9, 2017.
  • "Welcome," "Closing Remarks and Program Conclusion," Porzio Compliance Forum, Newark, NJ, February 10, 2017.
  • "The Intersection of Global Meetings and Global Transparency," CBI's 5th Annual Global Pharmaceutical and Medical Meetings Summit, Philadelphia, PA, February 1, 2017.
  • Anti-Trust Attorney, CBI's 3rd Annual Global Compliance Congress, London, UK, November 16, 2016.
  • Anti-Trust Attorney, CBI's 7th Annual West Coast Compliance Congress, San Francisco, CA, November 9, 2016.
  • "Understanding Federal and State Reporting Laws from All Corners," U.S. Healthcare Compliance Certification Program, Seton Hall Law School, Newark, NJ, October 26, 2016.
  • "HCP Interaction Risk Management," Moderator, 17th Annual Pharmaceutical Compliance Congress Best Practices Forum, Washington, DC, October 20, 2016.
  • "Structuring and Initiating Your Global Transparency Compliance Program," Moderator, CBI's 10th Annual Forum on Transparency and Aggregate Spend, Washington, DC, August 16, 2016.
  • "Understanding Federal and State Reporting Laws from All Corners," Seton Hall Healthcare Compliance Certification Program, Newark, NJ, June 15, 2016.
  • "Aggregate Spend Trends," Sales Operations Leadership Council Meeting, MedPro, Mt. Arlington, NJ, June 2, 2016. 
  • "Tips for Moving From Domestic to International Reporting and EFPIA-U.S. Reporting Requirements," CBI's 7th Annual West Coast Forum on Transparency and Aggregate Spend, San Diego, CA, May 18, 2016.
  • "Mini Summit XV: Advanced Issues in Applying Analytics - Using the Data to Provide Value and Partner with the Business," Panelist, The 10th International Pharmaceutical Congress and Best Practices Forum, Warsaw, Poland, May 11, 2016.
  • Track Chair, "Data Analysis, Risk Mitigation and Predictive Analytics," CBI's 13th Annual Pharmaceutical Compliance Congress, Washington, DC, April 27, 2016.
  • Summit Host, Chief Compliance Officer Summit, CBI's 13th Annual Pharmaceutical Compliance Congress, Washington, DC, April 26, 2016.
  • Moderator, "Informing HCPs Prior to Disclosure and Planning for Error Remediation," 6th Annual Global Transparency Reporting Congress, Frankfurt, Germany, April 7, 2016.
  • "State Laws that Could Delay Product Launch or Distribution," Seton Hall Law's West Coast Life Sciences Compliance Training Program, San Francisco, CA, March 22, 2016.
  • "Transparency - Present and Future," Synergistix 12th Annual Users Conference, Pompano Beach, FL, March 3, 2016.
  • "Data Analytics – How to Use Them to Predict Future Behavior," Moderator, Porzio Compliance Forum, Newark, NJ, December 3, 2015.
  • "Optimize Compliance Program Structure through Enhanced and Informed Resource Allocation," Moderator, CBI West Coast Compliance Congress, San Francisco, CA, November 5, 2015.
  • "Mini Summit VII: Predictive Analytics," 16th Pharmaceutical Compliance Congress and Best Practices Forum, Washington, DC, October 22, 2015.
  • "Understanding Federal and State Disclosure Laws From All Corners," Seton Hall Healthcare Compliance Certification Program, Seton Hall Law, Center for Health and Pharmaceutical Law & Policy, Newark, NJ, October 12, 2015.
  • "Open Payments/Sunshine Act:  Don't Get Burned By What You Don't Know," 2015 PDMA Sharing Conference, Baltimore, MD, September 27, 2015.   
    "Strategies to Reduce Compliance Risks and Optimize Commercial Programs Using Transparency Data Analytics," Panelist, CBI's 9th Annual Forum on Transparency and Aggregate Spend, Washington, DC, August 18, 2015.
  • "Lessons Learned From the First Two Years of Sunshine Reporting," Pharmaceutical and Life Sciences Accounting Conference, Iselin, NJ, June 11, 2015.
  • "Understanding Federal and State Reporting Laws from All Corners," U.S. Healthcare Compliance Certification Program, Seton Hall University School of Law, Newark, NJ, June 10, 2015.
  • Panel Moderator, "Leveraging Open Payments Data to Minimize Risks and Maximize Growth," CBI's 6th Annual Transparency Reporting West, San Diego, CA, April 21, 2015.
  • Panel Moderator, "Interpreting Lessons Learned from U.S. Open Payments Reporting (Sunshine Law) into Actionable Strategies for Managing HCP Relationships and Consent Agreements,"  CBI's 5th Annual Global Transparency  Reporting Congress, London, UK, April 15, 2015.
  • "Lessons Learned from the First Two Years of Sunshine Reporting," 2015 Synergistix Users Conference, Deerfield Beach, FL, March 12, 2015.
    "Open Payments Compliance and Dispute Resolution," Track Chair, CBI's 12th Annual Pharmaceutical Compliance Congress, Washington, DC, March 4, 2015.
  • "Welcome and Antitrust Guidelines Reminders," Chief Compliance Officer Summit Host, CBI's 12th Annual Pharmaceutical Compliance Congress, Washington, DC, March 3, 2015.
  • "Deep Dive on State Regulatory Changes for Sample Reporting," CBI's Sample Compliance and Reporting Summit, Philadelphia, PA, February 25, 2015.
  • "Ask the Experts Panel – "Strategies to Optimize Sample Compliance," Moderator, CBI's Sample Compliance and Reporting Summit, Philadelphia, PA, February 25, 2015.

37 Ex-US Jurisdictions Served

3 Offices

370 Companies Served

Questions? Request more information or call 973-538-1690

Contact Us